Mon. 22 Apr 2024, 8:33am ET
Benzinga
Biotech, News, General
Aslan Pharmaceuticals Reports Interim Results From Phase 2 Study Of Eblasakimab In Dupilumab-Experienced Atopic Dermatitis Patients
Company Profile